المؤلفون: William M. Mitchell

المصدر: Expert Review of Clinical Pharmacology

مصطلحات موضوعية: 0301 basic medicine, Agonist, Poly U, Rintatolimod, medicine.drug_class, Encephalomyelitis, dsRNA, clinical safety, Article, 03 medical and health sciences, clinical efficacy, Drug Profile, Interferon, medicine, Chronic fatigue syndrome, Animals, Humans, Pharmacology (medical), General Pharmacology, Toxicology and Pharmaceutics, RNA, Double-Stranded, Randomized Controlled Trials as Topic, clinical trials, Fatigue Syndrome, Chronic, business.industry, chronic fatigue/myalgic encephalomyelitis, General Medicine, medicine.disease, Protein kinase R, Immunity, Innate, 3. Good health, Toll-Like Receptor 3, Clinical trial, 030104 developmental biology, Poly I-C, TLR3, Immunology, TLR3 agonist, business, Ampligen, primate/non-primate disassociation of toxicity, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c2a16e5e9a1d88131ad9481ce16e2a7
https://pubmed.ncbi.nlm.nih.gov/27045557